Sign in

You're signed outSign in or to get full access.

David Allen

Director at MARIMED
Board

About David Allen

David Allen is an independent director of MariMed (MRMD), serving on the Board since June 2019 and currently age 70 . He is a licensed CPA with a bachelor’s in accounting and a master’s in taxation from Bentley College, and is an Associate Professor of Accounting at Southern Connecticut State University since 2017 (previously adjunct for 12 years) . Allen brings 28+ years of experience as a director, CEO, and CFO of public companies and is designated the Board’s “audit committee financial expert” under Item 407(d)(5) of Regulation S-K .

Past Roles

OrganizationRoleTenureCommittees / Impact
Iconic Brands, Inc.Chief Financial OfficerJul 2021 – May 2023Named defendant in the Iconic bankruptcy matter (involuntary petition Oct 16, 2023; converted to Chapter 7 Jan 5, 2024) .
Charlie’s Holdings, Inc. (formerly True Drinks)Chief Financial OfficerApr 2019 – Jun 2021Later served as Audit Committee Chair (Jun–Nov 2021) .
WPCS International, Inc.Chief Financial OfficerDec 2014 – Jan 2018Engineering firm focused on communications networks .
Bailey’s Express, Inc.Chief Financial Officer2004 – 2017Company filed Chapter 11 in Jul 2017; Allen served as Chapter 11 Plan Administrator until Dec 2020 .
Converted Organics, Inc.CFO & EVP of AdministrationJun 2006 – Jun 2013Previously Audit Committee Chair of the Board .
Southern Connecticut State UniversityAssociate Professor of Accounting2017 – presentAcademic role; prior 12 years as adjunct at SCSU and Western Connecticut State University .

External Roles

OrganizationRoleTenureNotes
Southern Connecticut State UniversityAssociate Professor of Accounting2017 – presentAcademic appointment; complements audit and financial oversight expertise .
Various public companies (prior)Director, CEO, CFO~28 years cumulativeBroad public company leadership experience .

Board Governance

  • Independence: The Board determined Allen is independent under Nasdaq rules; all three standing committees are composed entirely of independent directors .
  • Committee assignments: Audit Committee Chair and member; also member of Compensation Committee and Nominating & Governance Committee; qualifies as the “audit committee financial expert” .
  • Committee composition after Annual Meeting: Audit Committee (Allen—Chair, Gildea), Compensation (Allen, Gildea, Selhub—Chair Gildea), Nominating & Governance (Allen, Gildea, Selhub—Chair Selhub) .
  • Attendance: In fiscal 2024, the Board met 6 times; Audit 5; Compensation 3; Nominating & Governance 1; all directors attended at least 75% of Board and applicable committee meetings; all director nominees attended the 2024 annual meeting .

Fixed Compensation

  • Structure: Annual cash retainer of $40,000; annual equity grant of 75,000 RSUs vesting one year from grant; Committee Chair stipends: Audit $7,500, Compensation $5,000, Nominating & Governance $5,000; Chairman of the Board stipend $10,000 .
  • One-time stipend: In 2023, Allen received a special $25,000 stipend (paid in two $12,500 installments) for additional work performed .
YearFees Earned or Paid in CashStock Awards (ASC 718 FV)Total
2023$66,875 $30,375 $97,250
2024$47,500 $15,750 $63,250
Cash Retainer & Stipends (Policy)Amount
Annual Director Retainer$40,000
Audit Committee Chair$7,500
Compensation Committee Chair$5,000
Nominating & Governance Committee Chair$5,000
Chairman of the Board$10,000

Performance Compensation

  • RSU Grants:

    • 75,000 RSUs granted June 8, 2023; vest June 8, 2024; one-for-one into Common Shares; time-based vesting (no performance metrics disclosed) .
    • 75,000 RSUs granted June 6, 2024; vest June 6, 2025; one-for-one into Common Shares; time-based vesting (no performance metrics disclosed) .
  • Options:

    • Unexercised stock options of 100,000 (as of Dec 31, 2024) expiring July 9, 2026 .
    • In 2023 disclosure, 200,000 options outstanding with expirations: 100,000 expiring Sep 27, 2024 and 100,000 expiring Jul 9, 2026 .
    • 2021 policy stated annual options of up to 100,000 with five-year term at exercise price equal to fair value on grant date (historical framework; now replaced by RSU grants) .
Grant TypeGrant DateQuantityVest/ExpirationPerformance Metrics
RSUsJun 8, 202375,000 Vest Jun 8, 2024 None; time-based
RSUsJun 6, 202475,000 Vest Jun 6, 2025 None; time-based
Stock OptionsVarious (legacy)200,000 (2023 disclosure) 100,000 exp. Sep 27, 2024; 100,000 exp. Jul 9, 2026 Not performance-based (standard options)
Stock OptionsAs of 12/31/2024100,000 Exp. Jul 9, 2026 Not performance-based
  • Clawback: Awards under the 2018 Plan are subject to the Company’s clawback policy in effect at the time of grant .

Other Directorships & Interlocks

CompanyRoleStatusNotes
Public company directorshipsNone disclosedNo current external public boards disclosed in 2024–2025 proxies .
Charlie’s Holdings, Inc.Audit Committee ChairPastJun–Nov 2021; previously CFO .
Converted Organics, Inc.Audit Committee Chair (past), CFO & EVPPastBoard committee leadership prior to CFO role .

Expertise & Qualifications

  • Licensed CPA with deep CFO experience across multiple public companies; designated audit committee financial expert .
  • Academic expertise in accounting (Associate Professor at SCSU), supporting rigorous oversight of financial reporting and internal controls .
  • Significant restructuring exposure (Bailey’s Express Chapter 11; Iconic Brands bankruptcy involvement), indicating experience with distressed situations and creditor processes .

Equity Ownership

Record DateBeneficial Ownership (Shares)% of OutstandingComponents Noted
2024308,333 <1% Includes 200,000 options and 75,000 RSUs subject to vesting .
2025283,333 <1% Includes 100,000 options and 75,000 RSUs subject to vesting .
  • Insider trading policy prohibits hedging transactions (short sales, puts, calls) by directors; pre-clearance required for trades; no pledging policy disclosed; no pledges reported for Allen .

Governance Assessment

  • Board effectiveness: Allen’s role as Audit Committee Chair and audit committee financial expert strengthens oversight of financial reporting and auditor independence; committees composed entirely of independent directors per Nasdaq rules support governance quality .
  • Engagement: Attendance at least 75% across Board and committee meetings, with all nominees attending the annual meeting, indicates baseline engagement standards are met .
  • Pay and alignment: Director pay mix combines cash retainer and annual RSUs with one-year vesting; RSUs and legacy options create equity exposure, though beneficial ownership remains <1% of outstanding shares; awards subject to clawback add shareholder protection .
  • Conflicts/Red flags:
    • Iconic Brands bankruptcy matter—Allen is a named defendant in the Chapter 7 case, which could pose reputational and potential distraction risks; investors should monitor case progression and any financial implications or disclosures .
    • Prior involvement with companies that underwent bankruptcy (Bailey’s Express) signals experience in restructuring but may raise questions about historical outcomes; context suggests administrative leadership in plan wind-down .
    • No related-party transactions, tax gross-ups, or pledging disclosures specific to Allen identified in the proxies reviewed; hedging prohibited by policy .

RED FLAGS

  • Named defendant in Iconic Brands Chapter 7 bankruptcy proceeding (converted Jan 5, 2024) .
  • Historical association with Bailey’s Express Chapter 11; served as Plan Administrator through case closure (Dec 2020) .

Positive Signals

  • Independent status, audit financial expert designation, and chairing the Audit Committee, with committees comprised solely of independent directors .
  • Consistent meeting attendance and annual meeting participation .
  • Equity compensation subject to clawback under the 2018 Plan .